Reddy’s Gets Six-Month Head Start On Carboprost In US
• By Aidan Fry
Dr Reddy's is eligible for 180-day market exclusivity for the generic carboprost tromethamine vials it has just launched in the US • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
